Jacob Gottlieb: One Medical Venture at a Time

Our health is one of our critical assets in the entirety of our lifetime – without good health, we don’t live a long, full life. The main threats to our health is mainly sickness and diseases. Diseases have been the number one cause of human casualty for millenia. Plagues have wreaked havoc, epidemic have caused world wide panic, and all have taken their own shares of human life.

The key to the survival of human kind through all these years are human kind as well. As fast as these sicknesses pop out, our experts in the medical field get right on it on finding the cure to these sicknesses. Through research and technology, we have erased plagues and have cured lethal diseases. But there are still sicknesses that are fatal to humans that we have not yet found a solution to.

Jacob Gottlieb, a giant in the financial management world and a well-known philanthropist, is well aware of the fact that diseases evolve and so shall our technology and research to keep up with it. And those weapons against diseases need funding to roll on and on. Which is why Jacob Gottlieb’s newest financial venture, Altium Capital, is focused completely on this aspect.

Altium Capital, though based in. New York, has worldwide plans for the medical health care industry. Jacob Gottlieb’s vision for Altium Capital is to help propel the entire medical community forward with their medical advances in ultimate service to the whole human race Altium Capital was made for the sole purpose of getting investments for medical experts, research and practitioners to keep their work alive and running.

Some of the recent ventures of Altium Capital is Oramed Pharmaceuticals and Amarin Corporation – both of which are research and technology companies that are focused towards specific and specialized medicine – which are now running under Jacob Gottlieb’s help.

Find out more about Jacob Gottlieb: https://www.cnbc.com/jacob-gottlieb–cnbc/

Leave a Reply

Your email address will not be published. Required fields are marked *